All tenders
75N91021F00017

ELABORATION AND USE OF SYNGENIC PRE-CLINICAL MODELS FOR CANCER DRUG DEVELOPMENT

National Institutes of Health · United States

This contract has been awarded. Browse open opportunities
View Source

Time Left to Bid

Awarded

AwardedHealthcare & MedicalFederal

Basic information

Reference number
75N91021F00017
Government level
Federal
Solicitation type
Healthcare & Medical
Title
ELABORATION AND USE OF SYNGENIC PRE-CLINICAL MODELS FOR CANCER DRUG DEVELOPMENT
Source ID
usa-75N91021F00017

Details

Location
United States

Description

ELABORATION AND USE OF SYNGENIC PRE-CLINICAL MODELS FOR CANCER DRUG DEVELOPMENT Awarded to: LEIDOS BIOMEDICAL RESEARCH INC Agency: Department of Health and Human Services Sub-agency: National Institutes of Health Award type: DELIVERY ORDER

Dates

Publication
2021/09/16 12:00:00 AM UTC
Closing date
2029/08/21 12:00:00 AM UTC

Estimated value

$21.7M USD

Classification

Normalized category

Healthcare & Medical

Source: USASpending (Federal)

Last updated 2026-08-24, 8:46:50 p.m.

Data refreshed every 2 hours